The general objective of the iPAAC Joint Action (JA) is to develop innovative approaches to advances in cancer control. The innovation that will be covered within the JA consists of further development of cancer prevention, comprehensive approaches to the use of genomics in cancer control, cancer information and registries, improvements and challenges in cancer care, mapping of innovative cancer treatments and governance of integrated cancer control, including a new analysis of National Cancer Control Plans. The key focus of the Joint Action will be on implementation, as reflected in the key deliverable, i.e. the Roadmap on Implementation and Sustainability of Cancer Control Actions, which will support member states in the implementation of iPAAC and CANCON recommendations.
million EUR co-funding by EC
44 partners (Competent Authorities and Affiliated Entities)
04 Nov 2020
Reimbursement models for cancer surgery and radiation oncology
The evolving field of cancer therapy poses a real challenge for designing a reimbursement policy that can cope with providing a fair payment of the evidence-based standard of care and with the rapid pace of innovation.
14 Sep 2020
Online webinar Facing the harsh reality of pancreatic cancer: policy measures and health system strategies
An online webinar that continued in activities related to the improvement of pancreatic cancer care and the “Bratislava Statement” was held on 9 September 2020 under the umbrella of the iPAAC JA.
12 Aug 2020
The 2nd Czech Local Stakeholder Forum – top-level support of cancer control in the near future
The second Czech Local Stakeholder Forum took place on 5 June 2020 in Prague, with attendance of all cancer control stakeholders and policy makers – Czech Society for Oncology, health insurance companies, managers of healthcare facilities, and the Czech government.
24 Jun 2020
Consensus recommendations for pancreatic cancer care: the Bratislava Statement
Pancreatic cancer is one of the most lethal tumours, and it is the fourth cause of cancer death in Europe. Despite its important public health impact, however, there are no effective treatments or high-visibility research efforts.